Financial Gravity Asset Management, Inc. Novavax Inc Transaction History

Financial Gravity Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 26, 2024	BUY	$3.76 - $6.02 $15 - $24	4 Added 133.33%	7 $31,000
Q1 2024 May 13, 2024	BUY	$3.76 - $6.02 $45 - $72	12 Added 400.0%	15 $71,000
Q4 2023 Jun 26, 2024	SELL	$4.8 - $7.67 $57 - $92	-12 Reduced 80.0%	3 $16,000
Q3 2023 Nov 15, 2023	SELL	$6.81 - $9.74 $27 - $38	-4 Reduced 57.14%	3 $0
Q1 2023 May 12, 2023	SELL	$5.76 - $12.48 $17 - $37	-3 Reduced 30.0%	7 $4,000
Q4 2022 Feb 15, 2023	SELL	$8.86 - $25.04 $868 - $2,453	-98 Reduced 90.74%	10 $12,000
Q3 2022 Nov 03, 2022	BUY	$18.2 - $76.12 $1,965 - $8,220	108 New	108 $11,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.